Oral lipid-based formulations: enhancing the bioavailability of poorly water-soluable drugs
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York, NY
Informa Healthcare USA
2007
|
| Schriftenreihe: | Drugs and the pharmaceutical sciences
170 |
| Schlagworte: | |
| Online-Zugang: | Table of contents only Publisher description Inhaltsverzeichnis |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | XII, 339 S. Ill., graph. Darst. |
| ISBN: | 0824729455 9780824729455 |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV022656856 | ||
| 003 | DE-604 | ||
| 005 | 20071127 | ||
| 007 | t | ||
| 008 | 070829s2007 xxuad|| |||| 00||| eng d | ||
| 010 | |a 2007008964 | ||
| 020 | |a 0824729455 |c hb : alk. paper |9 0-8247-2945-5 | ||
| 020 | |a 9780824729455 |9 978-0-8247-2945-5 | ||
| 035 | |a (OCoLC)85817916 | ||
| 035 | |a (DE-599)DNB 2007008964 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-12 |a DE-19 | ||
| 050 | 0 | |a RS201.E87 | |
| 082 | 0 | |a 615/.1 | |
| 084 | |a VX 8550 |0 (DE-625)147830:253 |2 rvk | ||
| 245 | 1 | 0 | |a Oral lipid-based formulations |b enhancing the bioavailability of poorly water-soluable drugs |c ed. by David J. Hauss |
| 264 | 1 | |a New York, NY |b Informa Healthcare USA |c 2007 | |
| 300 | |a XII, 339 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Drugs and the pharmaceutical sciences |v 170 | |
| 500 | |a Includes bibliographical references and index | ||
| 650 | 4 | |a Lipides - Emploi en thérapeutique | |
| 650 | 4 | |a Médicaments - Formes pharmaceutiques | |
| 650 | 4 | |a Médicaments - Solubilité | |
| 650 | 4 | |a Solutions (Pharmacie) | |
| 650 | 4 | |a Lipids |x Therapeutic use | |
| 650 | 4 | |a Drugs |x Solubility | |
| 650 | 4 | |a Solutions (Pharmacy) | |
| 650 | 4 | |a Drugs |x Dosage forms | |
| 650 | 4 | |a Biological Availability | |
| 650 | 4 | |a Solubility |x drug effects | |
| 650 | 4 | |a Dosage Forms | |
| 650 | 4 | |a Drug Administration Routes | |
| 650 | 4 | |a Drug Delivery Systems |x methods | |
| 650 | 0 | 7 | |a Orales Arzneimittel |0 (DE-588)4274444-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Wasserlöslichkeit |0 (DE-588)4273707-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Lipide |0 (DE-588)4035873-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Wirkstofffreisetzung |0 (DE-588)4190018-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Orales Arzneimittel |0 (DE-588)4274444-1 |D s |
| 689 | 0 | 1 | |a Lipide |0 (DE-588)4035873-2 |D s |
| 689 | 0 | 2 | |a Wasserlöslichkeit |0 (DE-588)4273707-2 |D s |
| 689 | 0 | 3 | |a Wirkstofffreisetzung |0 (DE-588)4190018-2 |D s |
| 689 | 0 | |C b |5 DE-604 | |
| 700 | 1 | |a Hauss, David J. |e Sonstige |4 oth | |
| 830 | 0 | |a Drugs and the pharmaceutical sciences |v 170 |w (DE-604)BV000002008 |9 170 | |
| 856 | 4 | |u http://www.loc.gov/catdir/toc/ecip0712/2007008964.html |3 Table of contents only | |
| 856 | 4 | |u http://www.loc.gov/catdir/enhancements/fy0709/2007008964-d.html |3 Publisher description | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015862778&sequence=000005&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-015862778 | ||
Datensatz im Suchindex
| _version_ | 1804136836456513536 |
|---|---|
| adam_text | ORAL LIPID BASED FORMULATIONS ENHANCING THE BIOAVAILABILITY OF POOMLY
WATER-SOLUBLE DRUGS EDITED BY DAVID J. HAUSS BRISTOL-MYERS SQUIBB
COMPANY PRINCETON, NEW JERSEY, USA INFORMA HEALTHCARE NEW YORK LONDON
CONTENTS PREFACE .... VII CONTRIBUTORS .... XI 1. CURRENTLY MARKETED
ORAL LIPID-BASED DOSAGE FORMS: DRUG PRODUCTS AND EXCIPIENTS / ROBERT G.
STRICKLEY 2. LIPID-BASED EXCIPIENTS FOR ORAL DRUG DELIVERY 33 LOWELL
GIBSON 3. FEASIBILITY ASSESSMENT AND CONSIDERATIONS FOR SCALING INITIAL
PROTOTYPE LIPID-BASED FORMULATIONS TO PHASE I/II CLINICAL TRIAL BATCHES
63 PAUL SIROIS 4. MATERIALS, PROCESS, AND MANUFACTURING CONSIDERATIONS
FOR LIPID-BASED HARD-CAPSULE FORMATS 79 WILLIAM J. BOWTLE 5. LIQUID
SELF-MICROEMULSIFYING DRUG DELIVERY SYSTEMS 707 METTE GROVE ANDANETTE
MULLERTZ 6. LIPID-BASED ISOTROPIC SOLUTIONS: DESIGN CONSIDERATIONS 129
NAVNIT H. SHAH, WANTANEE PHUAPRADIT, YU-E ZHANG, HASHIM AHMED, AND A.
WASEEM MALICK IX X CONTENTS 7. LIPID-BASED SELF-EMULSIFYING SOLID
DISPERSIONS 149 MADHAV VASANTHAVADA AND ABU T. M. SERAJUDDIN 8. ORAL
LIPID-BASED FORMULATIONS: USING PRECLINICAL DATA TO DICTATE FORMULATION
STRATEGIES FOR POORLY WATER-SOLUBLE DRUGS 185 CHRISTOPHER J. H. PORTER
AND WILLIAM N. CHARMAN 9. PHYSIOLOGICAL PROCESSES GOVERNING THE
GASTROINTESTINAL ABSORPTION OF LIPIDS AND LIPOPHILIC XENOBIOTICS 207
RACHNA GAJJAR, CHUN-MIN LO, AND PATRICK TSO 10. CHARACTERIZING RELEASE
FROM LIPID-BASED FORMULATIONS 241 JENNIFER DRESSMAN, KAREN SCHAMP, KAREN
BELTZ, AND JOCHEM ALSENZ 11. USING IN VITRO DYNAMIC LIPOLYSIS MODELING
AS A TOOL FOR EXPLORING IVIVC RELATIONSHIPS FOR ORAL LIPID-BASED
FORMULATIONS 257 DIMITRIS G. FATOUROS ANDANETTE MULLERTZ 12. CASE
STUDIES: RATIONAL DEVELOPMENT OF SELF-EMULSIFYING FORMULATIONS FOR
IMPROVING THE ORAL BIOAVAILABILITY OF POORLY SOLUBLE, LIPOPHILIC DRUGS
273 PING GAO AND WALTER MOROZOWICH 13. DESIGN AND DEVELOPMENT OF
SUPERSATURATABLE SELF-EMULSIFYING DRUG DELIVERY SYSTEMS FOR ENHANCING
THE GASTROINTESTINAL ABSORPTION OF POORLY SOLUBLE DRUGS 303 PING GAO AND
WALTER MOROZOWICH INDEX 329
|
| adam_txt |
ORAL LIPID BASED FORMULATIONS ENHANCING THE BIOAVAILABILITY OF POOMLY
WATER-SOLUBLE DRUGS EDITED BY DAVID J. HAUSS BRISTOL-MYERS SQUIBB
COMPANY PRINCETON, NEW JERSEY, USA INFORMA HEALTHCARE NEW YORK LONDON
CONTENTS PREFACE . VII CONTRIBUTORS . XI 1. CURRENTLY MARKETED
ORAL LIPID-BASED DOSAGE FORMS: DRUG PRODUCTS AND EXCIPIENTS / ROBERT G.
STRICKLEY 2. LIPID-BASED EXCIPIENTS FOR ORAL DRUG DELIVERY 33 LOWELL
GIBSON 3. FEASIBILITY ASSESSMENT AND CONSIDERATIONS FOR SCALING INITIAL
PROTOTYPE LIPID-BASED FORMULATIONS TO PHASE I/II CLINICAL TRIAL BATCHES
63 PAUL SIROIS 4. MATERIALS, PROCESS, AND MANUFACTURING CONSIDERATIONS
FOR LIPID-BASED HARD-CAPSULE FORMATS 79 WILLIAM J. BOWTLE 5. LIQUID
SELF-MICROEMULSIFYING DRUG DELIVERY SYSTEMS 707 METTE GROVE ANDANETTE
MULLERTZ 6. LIPID-BASED ISOTROPIC SOLUTIONS: DESIGN CONSIDERATIONS 129
NAVNIT H. SHAH, WANTANEE PHUAPRADIT, YU-E ZHANG, HASHIM AHMED, AND A.
WASEEM MALICK IX X CONTENTS 7. LIPID-BASED SELF-EMULSIFYING SOLID
DISPERSIONS 149 MADHAV VASANTHAVADA AND ABU T. M. SERAJUDDIN 8. ORAL
LIPID-BASED FORMULATIONS: USING PRECLINICAL DATA TO DICTATE FORMULATION
STRATEGIES FOR POORLY WATER-SOLUBLE DRUGS 185 CHRISTOPHER J. H. PORTER
AND WILLIAM N. CHARMAN 9. PHYSIOLOGICAL PROCESSES GOVERNING THE
GASTROINTESTINAL ABSORPTION OF LIPIDS AND LIPOPHILIC XENOBIOTICS 207
RACHNA GAJJAR, CHUN-MIN LO, AND PATRICK TSO 10. CHARACTERIZING RELEASE
FROM LIPID-BASED FORMULATIONS 241 JENNIFER DRESSMAN, KAREN SCHAMP, KAREN
BELTZ, AND JOCHEM ALSENZ 11. USING IN VITRO DYNAMIC LIPOLYSIS MODELING
AS A TOOL FOR EXPLORING IVIVC RELATIONSHIPS FOR ORAL LIPID-BASED
FORMULATIONS 257 DIMITRIS G. FATOUROS ANDANETTE MULLERTZ 12. CASE
STUDIES: RATIONAL DEVELOPMENT OF SELF-EMULSIFYING FORMULATIONS FOR
IMPROVING THE ORAL BIOAVAILABILITY OF POORLY SOLUBLE, LIPOPHILIC DRUGS
273 PING GAO AND WALTER MOROZOWICH 13. DESIGN AND DEVELOPMENT OF
SUPERSATURATABLE SELF-EMULSIFYING DRUG DELIVERY SYSTEMS FOR ENHANCING
THE GASTROINTESTINAL ABSORPTION OF POORLY SOLUBLE DRUGS 303 PING GAO AND
WALTER MOROZOWICH INDEX 329 |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| building | Verbundindex |
| bvnumber | BV022656856 |
| callnumber-first | R - Medicine |
| callnumber-label | RS201 |
| callnumber-raw | RS201.E87 |
| callnumber-search | RS201.E87 |
| callnumber-sort | RS 3201 E87 |
| callnumber-subject | RS - Pharmacy |
| classification_rvk | VX 8550 |
| ctrlnum | (OCoLC)85817916 (DE-599)DNB 2007008964 |
| dewey-full | 615/.1 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.1 |
| dewey-search | 615/.1 |
| dewey-sort | 3615 11 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| discipline_str_mv | Chemie / Pharmazie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02764nam a2200673zcb4500</leader><controlfield tag="001">BV022656856</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20071127 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">070829s2007 xxuad|| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2007008964</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0824729455</subfield><subfield code="c">hb : alk. paper</subfield><subfield code="9">0-8247-2945-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780824729455</subfield><subfield code="9">978-0-8247-2945-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)85817916</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB 2007008964</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS201.E87</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.1</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VX 8550</subfield><subfield code="0">(DE-625)147830:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Oral lipid-based formulations</subfield><subfield code="b">enhancing the bioavailability of poorly water-soluable drugs</subfield><subfield code="c">ed. by David J. Hauss</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">Informa Healthcare USA</subfield><subfield code="c">2007</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XII, 339 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Drugs and the pharmaceutical sciences</subfield><subfield code="v">170</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipides - Emploi en thérapeutique</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Formes pharmaceutiques</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Solubilité</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Solutions (Pharmacie)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipids</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Solubility</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Solutions (Pharmacy)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Dosage forms</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biological Availability</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Solubility</subfield><subfield code="x">drug effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dosage Forms</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Administration Routes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Delivery Systems</subfield><subfield code="x">methods</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Orales Arzneimittel</subfield><subfield code="0">(DE-588)4274444-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wasserlöslichkeit</subfield><subfield code="0">(DE-588)4273707-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lipide</subfield><subfield code="0">(DE-588)4035873-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4190018-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Orales Arzneimittel</subfield><subfield code="0">(DE-588)4274444-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Lipide</subfield><subfield code="0">(DE-588)4035873-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Wasserlöslichkeit</subfield><subfield code="0">(DE-588)4273707-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4190018-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="C">b</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hauss, David J.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Drugs and the pharmaceutical sciences</subfield><subfield code="v">170</subfield><subfield code="w">(DE-604)BV000002008</subfield><subfield code="9">170</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/toc/ecip0712/2007008964.html</subfield><subfield code="3">Table of contents only</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/enhancements/fy0709/2007008964-d.html</subfield><subfield code="3">Publisher description</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015862778&sequence=000005&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-015862778</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV022656856 |
| illustrated | Illustrated |
| index_date | 2024-07-02T18:23:40Z |
| indexdate | 2024-07-09T21:02:44Z |
| institution | BVB |
| isbn | 0824729455 9780824729455 |
| language | English |
| lccn | 2007008964 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-015862778 |
| oclc_num | 85817916 |
| open_access_boolean | |
| owner | DE-12 DE-19 DE-BY-UBM |
| owner_facet | DE-12 DE-19 DE-BY-UBM |
| physical | XII, 339 S. Ill., graph. Darst. |
| publishDate | 2007 |
| publishDateSearch | 2007 |
| publishDateSort | 2007 |
| publisher | Informa Healthcare USA |
| record_format | marc |
| series | Drugs and the pharmaceutical sciences |
| series2 | Drugs and the pharmaceutical sciences |
| spelling | Oral lipid-based formulations enhancing the bioavailability of poorly water-soluable drugs ed. by David J. Hauss New York, NY Informa Healthcare USA 2007 XII, 339 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Drugs and the pharmaceutical sciences 170 Includes bibliographical references and index Lipides - Emploi en thérapeutique Médicaments - Formes pharmaceutiques Médicaments - Solubilité Solutions (Pharmacie) Lipids Therapeutic use Drugs Solubility Solutions (Pharmacy) Drugs Dosage forms Biological Availability Solubility drug effects Dosage Forms Drug Administration Routes Drug Delivery Systems methods Orales Arzneimittel (DE-588)4274444-1 gnd rswk-swf Wasserlöslichkeit (DE-588)4273707-2 gnd rswk-swf Lipide (DE-588)4035873-2 gnd rswk-swf Wirkstofffreisetzung (DE-588)4190018-2 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Orales Arzneimittel (DE-588)4274444-1 s Lipide (DE-588)4035873-2 s Wasserlöslichkeit (DE-588)4273707-2 s Wirkstofffreisetzung (DE-588)4190018-2 s b DE-604 Hauss, David J. Sonstige oth Drugs and the pharmaceutical sciences 170 (DE-604)BV000002008 170 http://www.loc.gov/catdir/toc/ecip0712/2007008964.html Table of contents only http://www.loc.gov/catdir/enhancements/fy0709/2007008964-d.html Publisher description GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015862778&sequence=000005&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Oral lipid-based formulations enhancing the bioavailability of poorly water-soluable drugs Drugs and the pharmaceutical sciences Lipides - Emploi en thérapeutique Médicaments - Formes pharmaceutiques Médicaments - Solubilité Solutions (Pharmacie) Lipids Therapeutic use Drugs Solubility Solutions (Pharmacy) Drugs Dosage forms Biological Availability Solubility drug effects Dosage Forms Drug Administration Routes Drug Delivery Systems methods Orales Arzneimittel (DE-588)4274444-1 gnd Wasserlöslichkeit (DE-588)4273707-2 gnd Lipide (DE-588)4035873-2 gnd Wirkstofffreisetzung (DE-588)4190018-2 gnd |
| subject_GND | (DE-588)4274444-1 (DE-588)4273707-2 (DE-588)4035873-2 (DE-588)4190018-2 (DE-588)4143413-4 |
| title | Oral lipid-based formulations enhancing the bioavailability of poorly water-soluable drugs |
| title_auth | Oral lipid-based formulations enhancing the bioavailability of poorly water-soluable drugs |
| title_exact_search | Oral lipid-based formulations enhancing the bioavailability of poorly water-soluable drugs |
| title_exact_search_txtP | Oral lipid-based formulations enhancing the bioavailability of poorly water-soluable drugs |
| title_full | Oral lipid-based formulations enhancing the bioavailability of poorly water-soluable drugs ed. by David J. Hauss |
| title_fullStr | Oral lipid-based formulations enhancing the bioavailability of poorly water-soluable drugs ed. by David J. Hauss |
| title_full_unstemmed | Oral lipid-based formulations enhancing the bioavailability of poorly water-soluable drugs ed. by David J. Hauss |
| title_short | Oral lipid-based formulations |
| title_sort | oral lipid based formulations enhancing the bioavailability of poorly water soluable drugs |
| title_sub | enhancing the bioavailability of poorly water-soluable drugs |
| topic | Lipides - Emploi en thérapeutique Médicaments - Formes pharmaceutiques Médicaments - Solubilité Solutions (Pharmacie) Lipids Therapeutic use Drugs Solubility Solutions (Pharmacy) Drugs Dosage forms Biological Availability Solubility drug effects Dosage Forms Drug Administration Routes Drug Delivery Systems methods Orales Arzneimittel (DE-588)4274444-1 gnd Wasserlöslichkeit (DE-588)4273707-2 gnd Lipide (DE-588)4035873-2 gnd Wirkstofffreisetzung (DE-588)4190018-2 gnd |
| topic_facet | Lipides - Emploi en thérapeutique Médicaments - Formes pharmaceutiques Médicaments - Solubilité Solutions (Pharmacie) Lipids Therapeutic use Drugs Solubility Solutions (Pharmacy) Drugs Dosage forms Biological Availability Solubility drug effects Dosage Forms Drug Administration Routes Drug Delivery Systems methods Orales Arzneimittel Wasserlöslichkeit Lipide Wirkstofffreisetzung Aufsatzsammlung |
| url | http://www.loc.gov/catdir/toc/ecip0712/2007008964.html http://www.loc.gov/catdir/enhancements/fy0709/2007008964-d.html http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015862778&sequence=000005&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000002008 |
| work_keys_str_mv | AT haussdavidj orallipidbasedformulationsenhancingthebioavailabilityofpoorlywatersoluabledrugs |